Self-reported inhaler use in patients with chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 104, Issue 1, 2010, Pages 99-106

  VanderSchaaf, Kory ^a   Olson, Kari L ^a,b   Billups, Sarah ^a,b   Hartsfield, Cynthia L ^c   Rice, Melissa ^a  

^a Pharmacy Department   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Abbott Global Pharmaceutical Research and Development   (United States)

Author keywords

Chronic obstructive; Data collection; Metered dose inhalers; Nebulizers and vaporizers; Patient compliance; Pulmonary disease

Indexed keywords

IPRATROPIUM BROMIDE; OXYGEN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG COST; DRUG SELF ADMINISTRATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SPIROMETRY;

AGED; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; MALE; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SPIROMETRY;

EID: 73749083041     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.07.003     Document Type: Article

References (24)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
2. National Center for Health Statistics. Deaths: preliminary data 2006 (2008), US Department of Health and Human Services, CDC, Hyattsville, MD (National Vital Statistics Report; vol. 56, no. 16)
3. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
4. Harvey P.A., Murphy M.C., Dornom E., Berlowitz D.J., Lim W.K., and Jackson B. Implementing evidence-based guidelines: inpatient management of COPD. Intern Med J 35 (2005) 151-155
5. Incalzi R.A., Corsonello A., Pedone C., et al. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice: an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder. Drugs Aging 23 (2006) 411-420
6. Barr R.G., Celli B.R., Martinez F.J., et al. Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med 118 (2005) 1415
7. Bednarek M., Maciejewski J., Wozniak M., Kuca P., and Zielinski J. Prevalence, severity, and under-diagnosis of COPD in primary care setting. Thorax 63 (2008) 402-407
8. Rand C.S., Nides M., Cowles M.K., Wise R.A., and Connett J. Long-term metered-dose inhaler adherence in a clinical trial: The Lung Health study Research Group. Am J Respir Crit Care Med 152 (1995) 580-588
9. James P.N., Anderson J.B., Prior J.G., White J.P., Henry J.A., and Cochrane G.M. Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J 61 (1985) 7-10
10. Boyter A.C., and Carter R. How do patients use their nebuliser in the community?. Respir Med 99 (2005) 1413-1417
11. Cramer J.A., Bradley-Kennedy C., and Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 14 (2007) 25-29
12. Dolce J.J., Crisp C., Manzella B., Richards J.M., Hardin J.M., and Bailey W.C. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 99 (1991) 837-841
13. George J., Kong D.C., Thoman R., and Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 128 (2005) 3198-3204
14. Turner J., Wright E., Mendella L., Anthonisen N., and the IPPB (Intermittent Positive Pressure Breathing) Study Group. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 108 (1995) 394-400
15. World Health Organization. Adherence to long-term therapies: evidence for action. Available from: (2003). www.who.int/chp/knowledge/publications/adherence_report/en/index.html [accessed 21.06.09]
16. Restrepo R.D., Alvarez M.T., Wittnebel L.D., et al. Medication adherence issues in patients treated for COPD. Int J Chronic Obstruct Pulmon Dis 3 (2008) 371-384
17. Breekveldt-Postma N.S., Koerselman J., Erkens J.A., Lammers J.W., and Herings R.M. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 101 (2007) 1398-1405
18. Turner J., Wright E., Mendella L., and Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 108 (1995) 394-400
19. Hansen R.A., Kim M.M., Song L., Tu W., Wu J., and Murray M.D. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 43 (2009) 413-422
20. Gatti M.E., Jacobson K.L., Gazmararian J.A., Schmotzer B., and Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm 66 (2009) 657-664
21. Stuart M., and Weinrich M. Integrated health system for chronic disease management. Chest 125 (2004) 695-703
22. Maio V., Pizzi L., Roumm A.R., et al. Pharmacy utilization and the medicare modernization act. Milbank Q 83 (2005) 101-130
23. George J., Kong D.C., and Stewart K. Adherence to disease management program in patient with COPD. Int J Chronic Obstruct Pulmon Dis 2 (2007) 253-262
24. Bourbeau J., and Bartlett S.J. Patient adherence in COPD. Thorax (2008) 831-838